Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
about
Nail PsoriasisInterventions for nail psoriasisNail Psoriasis: A Review of Treatment OptionsTailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapiesEQ-5D in skin conditions: an assessment of validity and responsivenessBiologic agents in nail psoriasis: efficacy data and considerations.[Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy].Nail psoriasis: the journey so far.Treatment of nail psoriasis: common concepts and new trendsNail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features.Nail psoriasis as a severity indicator: results from the PsoReal study.Development of the International Classification of Functioning, Disability and Health core sets for hand conditions--results of the World Health Organization International Consensus process.Treatment of inflammatory nail disorders.Nail psoriasis: a review of the literatureUse of biologics for psoriasis in Central and Eastern European countries.Treatment of psoriasis with etanercept: the typical patient profile.Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis.A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity.New developments in our understanding of psoriatic arthritis and their impact on the diagnosis and clinical management of the disease.Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study.Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study.Dramatic response of nail psoriasis to infliximab.TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis.A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis.Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial.Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients.Treatment of nail psoriasis with tumor necrosis factor-alpha blocker agents: an open-label, unblinded, comparative study.Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study.Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3.[Systemic treatments for psoriasis and psoriatic arthritis].[Psoriasis in special localizations].Optimal management of nail disease in patients with psoriasis.Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study
P2860
Q22305813-1A0D5766-258E-47F8-AF0F-28FD8538A367Q24201549-136B516A-1B49-4C15-B6FC-E74A81E9EA44Q26753038-9F1B1F41-584D-4CF8-BBE4-D7A44F64E58BQ26764867-B0CF7B82-F99A-4A24-9F19-7315A1F06402Q27011276-94AE3814-592D-4940-9C29-E7384E23C6C7Q30683539-4171C0EB-946D-4D24-8340-039A443686E6Q34636311-230D8C0B-9D50-432F-B91D-7EEB8DA01741Q34663564-012B29C5-403F-4DF6-90F8-92C816775F6EQ34769284-158CAC68-C315-42D9-894C-2F5B5C5BE131Q35892189-064CEA95-C5AB-496A-8222-5FD2279D5B1CQ36160601-8BDC8C5C-3B2E-4857-9C82-74CF5DAB500EQ37943005-60C35EC8-C42B-41AF-BC3B-560265041F97Q38064924-C4FE9E9D-177A-45FF-A35D-B8847603DF2AQ38207482-6E35EB2E-B799-4C40-8E44-81BF2A7433E9Q38586836-98C95F13-5789-401F-BB4B-91E56707EB30Q38807058-435ABCCE-5E16-4F38-BBC2-B7A11B7D008DQ38841466-61E418FA-85A9-44A0-BD38-B90B501A7429Q38858335-0FAB6D97-54DD-479C-9C7C-2FF4B02F97B4Q39078782-FB97E5A4-3175-4CE7-A855-9687001132F8Q39373505-ED8597B5-2F4C-43AF-AD7D-6D264C4404CAQ40055626-19163549-4346-49A2-93BE-EDE5260F3163Q42611071-9BE6EA73-5685-43F2-AEFD-E05F5FEB206AQ42737181-92FFC2BC-2EB1-430B-A5BB-552810D205A5Q44019438-D84D33A4-4B18-41CD-A4C0-8A9BE3B18868Q44639027-01FB891C-0426-409D-999B-2618F01883E5Q44874974-79697BAC-49F4-4B72-BBF3-F388AC84642AQ45338010-1BDEAE51-60F6-4FCD-883D-094AC882DAE4Q45890797-2CDBEB6A-57F5-4235-A81B-39004E965038Q45993964-96D23D5B-064B-4298-A427-B6C3D551AF7CQ51032219-3672A9F9-9267-4FB0-88EA-649A45D27298Q52851716-DB847069-1F9A-4813-ADA6-C2A25B65AB1CQ52851991-2779DD63-8621-43F8-AD70-F3CA6415AA17Q55192665-E9129F8E-5CD7-497C-9279-AE594BD6F934Q56943591-F9CD8CD3-849D-4110-B155-3A5DFFD765B8
P2860
Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Sustained improvement in joint ...... moderate-to-severe psoriasis.
@en
Sustained improvement in joint ...... moderate-to-severe psoriasis.
@nl
type
label
Sustained improvement in joint ...... moderate-to-severe psoriasis.
@en
Sustained improvement in joint ...... moderate-to-severe psoriasis.
@nl
prefLabel
Sustained improvement in joint ...... moderate-to-severe psoriasis.
@en
Sustained improvement in joint ...... moderate-to-severe psoriasis.
@nl
P2093
P1476
Sustained improvement in joint ...... h moderate-to-severe psoriasis
@en
P2093
D Robertson
P304
P356
10.1111/J.1468-3083.2009.03211.X
P577
2009-05-03T00:00:00Z